Trump administration rejects idea of testing the country back to pre-pandemic normal

Trump administration rejects idea of testing the country back to pre-pandemic normal
A further massive increase in the availability of tests for the coronavirus could functionally end the pandemic and return life to normal, many public health experts and economists say. The Trump administration's coronavirus testing czar, though, rejects the idea.

“You never have enough tests because it's not one and done,” said Peter Pitts, the former Food and Drug Administration associate commissioner and president and co-founder of the think tank, the Center for Medicine in the Public Interest. “It's not as though I get tested on the list, I'll never need to be tested again. People will need to be tested many times.”

In the view of many public health experts, widespread testing for both symptomatic and asymptomatic people would allow many people to return to their pre-pandemic lives. Today, in contrast, the Centers for Disease Control and Prevention recommends that testing should only be used for people who have symptoms or were exposed to the virus or for public surveillance. The approach has limited the spread of the disease. But outside experts argue that the administration should prioritize the development and distribution of cheap, easy-to-use tests so that people could test themselves regularly. Doing so would allow the vast majority of people to go about their lives without fear of spreading the disease, they say.

 
Sign Up for Our Email Newsletter

RECENT NEWS

The Spreading Cancer of Counterfeit Drugs
  • CMPI
  • 10/01/2020 12:00 AM

The Spreading Cancer of Counterfeit Drugs

Just as the coronavirus mutates to survive and thrive, so to do the purveyors of counterfeit medicines -- with their high...  Read more

$40 price tag for potential coronavirus vaccine seems to be ‘right on the money,’ says think tank

$40 price tag for potential coronavirus vaccine seems to be ‘right on the money,’ says think tank

If a potential coronavirus vaccine is not affordable, too many people will not get vaccinated, says Peter Pitts, presiden...  Read more

Former FDA Associate Commissioner Says FDA Made Right Move to Authorize Convalescent Plasma

Former FDA Associate Commissioner Says FDA Made Right Move to Authorize Convalescent Plasma

Peter Pitts, President for the Center For Medicine in the Public Interest, explains why he believes the FDA authorized th...  Read more

DRUGWONKS BLOG